ArticleBMC cancer2024

Clinical outcomes for immune checkpoint inhibitors plus chemotherapy in non-small-cell lung cancer patients with uncommon driver gene alterations.

Haoyue Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.